Ted Slafsky, publisher and CEO of 340B Report, writes about Medicare drug price negotiations and the 340B program.
Column: CMS Should Heed the Advice of 340B Community on Medicare Negotiations
The Biden administration deserves credit for playing a key role in passing the first law in history to allow the [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.